Novavax | NVAX - Umsatzerlöse

Aktienkurs
8.12
Täglich Wechseln
-0.42 -4.92%
Monatlich
-24.81%
Jährlich
38.57%
Q2 Prognose
7.90




Der Umsatz Veränderung Datum
Adma Biologics USD 139.16M 4.94M 2025-12
Agenus USD 34.2M 3.97M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Geron USD 48.02M 820K 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
MannKind USD 111.96M 29.83M 2025-12
Merck USD 16.4B 880M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 678M 342M 2025-12
Novartis USD 13.86B 498M 2025-12
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 17.58B 880M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12